A patient hands a pharmacist a prescription for Spondicin 20 mg (fictitious), a prescription-only drug. As the patient is waiting for the prescription to be filled, the patient notices that Spondicin 10 mg is available OTC and asks the pharmacist how it can be that one strength is prescription only and the other is OTC. What should the pharmacist say? Would the pharmacist violate the FDCA by telling the patient to use the OTC drug for the prescribed indication in the prescribed dose when that indication or dosage is not contained in the OTC drug’s labeling?